Company: XAIR
Filing Date: 2025-02-10
Form Type: 10-Q
Source: 0001493152-25-005678
Chunk: 106

Company: Beyond Air, Inc.
Filing Date: 2025-02-10
Form: 10-Q
Item: Part II, Item 8
Chunk 106
---
- 

As
of December 31, 2024, the Company had unrecognized stock-based compensation expense in the 2013 BA Plan of approximately $4.9 million
which was expected to be expensed over the weighted average remaining service period of 1.8 years.

As
of December 31, 2024, the Company had unrecognized stock-based compensation expense in the 2021 BC Plan of approximately $3.6 million
which is expected to be expensed over the weighted average remaining service period of 1.2 years.

     19 

BEYOND
AIR, INC. AND SUBSIDIARIES

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE
4 STOCKHOLDERS’ EQUITY (continued)

The
following was utilized to calculate the fair value of options on the date of grant:

SCHEDULE OF FAIR VALUE OF OPTION 

    December
    31, 2024

    December
    31, 2023

    Risk-free
    interest rate

    4.3
    – 4.4
    %

    4.3
    – 4.9
    %
  
    Expected
    volatility (Beyond Air)

    81.4
    – 89.6
    %

    81.4
    – 81.7
    %
  
    Expected
    volatility (Beyond Cancer)

    -

    104.3
    -106.2
    %
  
    Dividend
    yield

    0
    %

    0
    %
  
    Expected
    terms (in years)

    6.25

    6.25

The
following summarizes the components of stock-based compensation expense which included stock options and restricted stock units for the
three and nine months ended December 31, 2024 and December 31, 2023:

SCHEDULE
OF STOCK-BASED COMPENSATION EXPENSE

    (in thousands) 
    2024  
    2023  
    2024  
    2023 

    Three Months Ended  
    Nine Months Ended 

    December 31,  
    December 31, 
  
    (in thousands) 
    2024  
    2023  
    2024  
    2023 
  
    Research and development